Hansen Gwenn (CIK 1817160) reported 34 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-05). Recent activity: Sell NRIX (1,500 shares), Buy NRIX (4,356 shares), Sell NRIX (4,356 shares), Sell NRIX (2,611 shares), Buy NRIX (3,750 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-05 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 1,500 | $35,803 |
| 2026-08-05 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 4,356 | $8,102 |
| 2026-08-05 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 4,356 | $108,900 |
| 2026-08-05 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 2,611 | $64,339 |
| 2026-07-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 3,750 | $0 |
| 2026-07-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 2,858 | $0 |
| 2026-07-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 3,572 | $0 |
| 2026-07-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 3,847 | $89,954 |
| 2026-06-25 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 5,394 | $107,880 |
| 2026-04-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 3,214 | $53,498 |
| 2026-04-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 3,750 | $0 |
| 2026-04-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 2,858 | $0 |
| 2026-04-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 2,000 | $0 |
| 2026-02-03 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 31,333 | $26,320 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 3,207 | $0 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 2,000 | $0 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 3,750 | $0 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 2,859 | $0 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 4,797 | $79,534 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 98 | $1,702 |
| 2025-10-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 3,207 | $0 |
| 2025-10-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 2,000 | $0 |
| 2025-10-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 3,750 | $0 |
| 2025-10-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 4,087 | $52,314 |
| 2025-10-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 2,858 | $0 |
Source: SEC Form 4 filings · as of 2026-08-05